In-clinic therapies
From comprehensive NAD+ restoration to cellular health maintenance. Each format is manufactured to pharmaceutical-grade standards and administered by licensed healthcare professionals.
Your comfort, prioritized
Traditional NAD+ IV protocols are known for discomfort that limits infusion rate and extends session time.
Niagen IV was developed for a different experience: peer-reviewed clinical data documents a tolerability profile with only minor, transient experiences during infusion.² ³
Your time, restored
A pilot study revealed that Niagen IV increases NAD+ levels more than 20% within 3 hours post-infusion, with 75% less infusion time than NAD+ IV.¹
Pharmaceutical-grade NAD+ restoration, designed to complement your schedule.³
Our standard, upheld
Two clinical studies. Controlled methodology.¹ Peer-reviewed, real-world confirmation.² No other NAD+-boosting IV carries the level of clinical documentation that Niagen® NR IV does including NAD+ IV itself.
Administered by licensed healthcare professionals, with peer-reviewed real-world data documenting tolerability over a 30 days follow-up period.² ³
Cellular support in minutes
Every Niagen Shots vial is compounded by a licensed 503B outsourcing facility operating under cGMP standards, with third-party verification of purity and potency.
Administered by a licensed healthcare professional at select clinics nationwide, with no extended sessions and no lengthy preparation.³
"What excites me most about Niagen IV therapy is that we're not chasing a quick fix. We're playing the long game for healthy aging and longevity. The data we're collecting on sleep, energy, and cognitive clarity is growing more compelling with every person we study".
Access Niagen Plus near you
Cellular health science meets world-class hospitality.
- Pharmaceutical-grade therapy delivered with clinical oversight
- The same precision Niagen® at every participating clinic
- Available at 1200+ premium locations nationwide
- Schedule a concierge clinical session for in-office or in-home therapy
- Hawkins J, Idoine R, Kwon J, Shao A, Dunne E, Hawkins E, Dawson K, Nkrumah-Elie Y. Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adults. medRxiv. 2024. doi: 10.1101/2024.06.06.24308565. This study is a preprint and has not yet been peer-reviewed.
- Reyna K, Heinzen G, Patel N, Ritter M, Siojo A, Legere H, Pojednic R. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Front Aging. 2026 Feb 2;7:1652582. doi: 10.3389/fragi.2026.1652582.
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
